Serum levels of recently discovered circulating forms of adhesion molecules, ICAM-1 and L-selectin, were found to be elevated in IDDM patients and in subjects at risk for developing IDDM compared with 100 normal, nondiabetic blood donors. Both adhesion molecules were determined by sandwich ELISA. Serum concentrations of either clCAM-1 or cL-selectin were >2SD of normal mean in 10 of 14 recent-onset IDDM patients (P < 0.05). Serum levels of clCAM-1 and cL-selectin did not correlate. In first-degree relatives, elevated adhesion molecule levels were observed in the 6 ICA+ individuals and in the ICA− individuals all (n = 14) with a genetic risk of IDDM (sharing HLA-DR3 and/or -DR4− with the diabetic relative) but not in the HLA-DR3− and/or -DR4− relatives (n = 13). We conclude that elevated clCAM-1 and cL-selectin levels occur independently of ICA status and probably reflect ongoing immune processes in recent-onset IDDM patients and first-degree relatives at risk for IDDM.
Skip Nav Destination
Article navigation
Rapid Publications|
December 01 1992
Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM
Eberhard R Lampeter;
Eberhard R Lampeter
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Takashi K Kishimoto;
Takashi K Kishimoto
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Robert Rothlein;
Robert Rothlein
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Elizabeth A Mainolfi;
Elizabeth A Mainolfi
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Jorg Bertrams;
Jorg Bertrams
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Hubert Kolb;
Hubert Kolb
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Stephan Martin
Stephan Martin
Diabetes Research Institute at The Heinrich-Heine-University
Dusseldorf
Elisabeth Hospital
Essen, Germany
Boehringer Ingelheim Pharmaceuticals
Ridgefield, Connecticut
Center for Blood Research
Boston, Massachusetts
Search for other works by this author on:
Address correspondence and reprint requests to Stephan Martin, MD, Diabetes Research Institut, Auf'm Hennekamp 65, 4000 Dusseldorf 1, Germany.
Diabetes 1992;41(12):1668–1671
Article history
Received:
July 23 1992
Revision Received:
September 20 1992
Accepted:
September 20 1992
PubMed:
1280239
Citation
Eberhard R Lampeter, Takashi K Kishimoto, Robert Rothlein, Elizabeth A Mainolfi, Jorg Bertrams, Hubert Kolb, Stephan Martin; Elevated Levels of Circulating Adhesion Molecules in IDDM Patients and in Subjects at Risk for IDDM. Diabetes 1 December 1992; 41 (12): 1668–1671. https://doi.org/10.2337/diab.41.12.1668
Download citation file:
64
Views